The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

The nonprofit Companion Animal Parasite Council (CAPC) – the leading authority on vector-borne diseases affecting pets and ...

Introduction: The DNA of a Biotech BoomThe global plasmid DNA manufacturing market is entering a transformative era, driven ...

Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The ...

Alexandra Mousavizadeh explores how banks are operationalising Responsible AI across the AI lifecycle to stay competitive and ...

Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, ...

In a world where information travels far faster than infections, it is more important than ever to think critically about ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

The COVID-19 pandemic demonstrated that the mass production of vaccines is crucial for our healthcare system. In order to ...

As biologics such as vaccines, gene therapy and therapeutic proteins continue to advance to commercial viability, their ...